SCHEMBL1970629

SCHEMBL1970629

CCCCOC(=O)N1CCc2c(C#N)c(N)n(C)c(=S)c2C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.47
GAA P10253 5/20 0.47
KDM4E B2RXH2 4/20 0.47
ALDH1A1 P00352 5/20 0.42
KMT2A Q03164 5/20 0.42
MEN1 O00255 4/20 0.42
GLA P06280 1/20 0.42
HSD17B10 Q99714 2/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
LMNA P02545 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
POLB P06746 2/20 0.37
PTGDR2 Q9Y5Y4 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.35
BPTF Q12830 1/20 0.35
HRH2 P25021 3/20 0.33
HRH1 P35367 3/20 0.33
HRH3 Q9Y5N1 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3141072 0.81 MAPT (0.46) MAPTGAAKDM4EALDH1A1KMT2A
SCHEMBL1964761 0.72 ALDH1A1 (0.58) MAPTGAAKDM4EALDH1A1KMT2A
SCHEMBL4788829 0.69 ALDH1A1 (0.44) MAPTGAAKDM4EALDH1A1KMT2A
SCHEMBL29360309 0.67 SMN1; SMN2 (0.46) MAPTGAAKDM4EALDH1A1KMT2A
SCHEMBL7380124 0.67 SMN1; SMN2 (0.54) MAPTKDM4EALDH1A1KMT2AMEN1
SCHEMBL34473620 0.66 LMNA (0.42) MAPTGAAKDM4ELMNASMN1; SMN2
SCHEMBL3347382 0.65 MAPT (1.00) MAPTGAAKDM4EALDH1A1KMT2A
SCHEMBL940506 0.65 MAPT (0.61) MAPTGAAKDM4EALDH1A1KMT2A
SCHEMBL14423277 0.65 PTGDR2 (0.41) MAPTGAAKDM4EALDH1A1KMT2A
SCHEMBL3697057 0.64 LMNA (0.51) KDM4EALDH1A1LMNASMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2334676-A1 SUBSTITUTED 3 -AMIN0- 1-0X0 OR THIOXO-I, 2,5,6,7, 8-HEXAHYDR0-2, 7-NAPHTHYRIDINE-4-CARB0NITRILES AS SELECTIVE ALPHA 2B ANTAGONISTS Allergan, Inc. (US) 2011-06-22 EP disclosed